FCBT
ABMD

First Citizens Bank & Trust’s Abiomed Inc ABMD Stock Holding History

First Citizens Bank & Trust’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,081
Closed -$358K – 465
2022
Q1 		$358K Buy
+1,081
New +$333K 0.01% 269

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

First Citizens Bank & Trust's ABMD Position: Q2 2022 in Review

First Citizens Bank & Trust sold out of Abiomed Inc (ABMD) in Q2 2022, closing a stake of 1,081 shares — an estimated $358K sold.

First Citizens Bank & Trust first reported a position in ABMD in Q1 2022 and held it in 1 quarter. The position peaked at $358K in Q1 2022. 496 funds tracked by Wall St. Rank hold ABMD as of Q2 2022.

  • First Citizens Bank & Trust reported no remaining Abiomed Inc position as of Q2 2022 after selling out during the quarter.
  • First Citizens Bank & Trust sold 1,081 Abiomed Inc shares in Q2 2022, an estimated $358K.
  • First Citizens Bank & Trust first reported a position in Abiomed Inc in Q1 2022 and held it in 1 quarter.
  • First Citizens Bank & Trust's Abiomed Inc position peaked at $358K in Q1 2022.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2022.

Based on First Citizens Bank & Trust's 13F filing for Q2 2022, filed 26 Jul 2022.